Condition: Hypertension · Sponsor: Mineralys Therapeutics Inc.
This is a Phase 3 trial to evaluate the BP-lowering effect of lorundrostat (an aldosterone synthase inhibitor) in subjects with uncontrolled and resistant hypertension taking between 2 and 5 anti-hypertensive (AHT) medications.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Advanced Cardiovascular, LLC - Alexander City Office | Alexander City, Alabama, United States | — |
| Central Research Associates, Inc | Birmingham, Alabama, United States | — |
| Cardiology, P.C. | Birmingham, Alabama, United States | — |
| Synexus (Radiant Research, Inc) - Alabama - Simon Williamson Clinic Location | Birmingham, Alabama, United States | — |
| G & L Research LLC - Foley | Foley, Alabama, United States | — |
| Accel Research Sites (ARS) - Birmingham Clinical Research Unit | Vestavia Hills, Alabama, United States | — |
| Del Sol Research | Tucson, Arizona, United States | — |
| Entertainment Medical Group, Inc. | Beverly Hills, California, United States | — |
| Amicis Research Center - Granada Hills | Granada Hills, California, United States | — |
| Amicis Research Center - Northridge | Granada Hills, California, United States | — |
| Marvel Clinical Research, LLC | Huntington Beach, California, United States | — |
| Amicis Research Center | Northridge, California, United States | — |
+ 172 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.